Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-01-22 @ 1:43 AM
Study NCT ID:
NCT07208058
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
Sponsor:
TJ Biopharma Co., Ltd.
Organization: